Discover
ASBP
Aspire Biopharma Holdings, Inc.
5.86
2 x 4.17
2 x 6.56
bid
ask
+
0.52
9.74%
2 @ 06:13 AM
5.66 -0.20 (3.41%)
| Ytd | 10.98% | |
| 1y | -52.74% |
5.13
day range
5.88
0.11
52 week range
35.00
| Open | 5.40 | Prev Close | 5.34 | Low | 5.13 | High | 5.88 | Mkt Cap | 7.59M |
| Vol | 132.72K | Avg Vol | 13.34M | EPS | -7.09 | P/E | N/A | Forward P/E | N/A |
| Beta | N/A | Short Ratio | N/A | Inst. Own | N/A | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | N/A | 50-d Avg | 4.25 | 200-d Avg | 5.26 | 1yr Est | 0.00 |
| Income Statement | |||
| Total Revenue | 28.35K | ||
| Revenues (USD) | 28.35K | ||
| Cost of Revenue | 22.60K | ||
| Gross Profit | 5.75K | ||
| Operating Expenses | 1.65M | ||
| Research and Development Expense | 296.72K | ||
| Selling, General and Administrative Expense | 1.36M | ||
| Operating Income | -1.65M | ||
| Interest Expense | 1.60M | ||
| Net Income | -3.22M | ||
| Net Income Common Stock | -3.22M | ||
| Net Income Common Stock (USD) | -3.22M | ||
| Consolidated Income | -3.22M | ||
| Earnings per Basic Share | -20.57 | ||
| Earnings per Basic Share (USD) | -20.57 | ||
| Earnings per Diluted Share | -20.57 | ||
| Earning Before Interest & Taxes (EBIT) | -1.63M | ||
| Earning Before Interest & Taxes (USD) | -1.63M | ||
| Weighted Average Shares | 156.69K | ||
| Weighted Average Shares Diluted | 156.69K | ||
| Balance Sheet | |||
| Cash and Equivalents | 5.86M | ||
| Cash and Equivalents (USD) | 5.86M | ||
| Current Assets | 7.12M | ||
| Total Assets | 7.12M | ||
| Debt Current | 1.50M | ||
| Total Debt | 1.50M | ||
| Current Liabilities | 3.15M | ||
| Total Liabilities | 3.25M | ||
| Accumulated Retained Earnings (Deficit) | -30.48M | ||
| Shareholders Equity | 3.87M | ||
| Shareholders Equity (USD) | 3.87M | ||
| Total Debt (USD) | 1.50M | ||
| Inventory | 369.97K | ||
| Liabilities Non-Current | 96.25K | ||
| Trade and Non-Trade Payables | 1.21M | ||
| Cash Flow | |||
| Net Cash Flow from Financing | 7.89M | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | 4.85M | ||
| Issuance (Repayment) of Debt Securities | -1.06M | ||
| Net Cash Flow from Operations | -3.04M | ||
| Share Based Compensation | 13.41K | ||